Advertisement

Evidence for Alterations of Brain Morphology and Function in Subgroups of Schizophrenic Subjects

  • Göran Sedvall
  • Gustaf Bergstrand
  • Lars Bjerkenstedt
  • Henrik Nybäck
  • Gabriella Oxenstierna
  • Frits-Axel Wiesel

Abstract

The concept of functional psychosis implicates the occurrence of psychosis in patients where no structural brain damage can be demonstrated. The development in neurobiology over the last few years makes it reasonable to assume that the elaboration of new sophisticated methods in the future will have great implications for the diagnostic classification of functional psychoses. New biochemical and neuroradiological methods have been developed during the past two decades. These methods are already today applied to groups of psychiatric patients. A number of altered functions in patients with functional psychosis have already been demonstrated with such methods.

Keywords

Schizophrenic Patient Brain Atrophy Schizophrenic Subject Monoamine Metabolite Functional Psychos 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Nybäck, H., Wiesel, F.-A., Berggren, B.-M. and Hindmarsh, T., 1982, Computed tomography of the brain in patients with acute psychosis and in healthy volunteers. Acta Psychiat. Scand., 65:403.Google Scholar
  2. Nybäck, H., Berggren, B.-M., Hindmarsh, T., Sedvall, G. and Wiesel, F.-A., 1983, Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers. Psychiatry Res., in pressGoogle Scholar
  3. Oxenstierna, G., Bergstrand, G., Sedvall, G. and Wik, G., 1983, Evidence for a disturbed CSF circulation in cases of schizophrenic psychosis. In preparation.Google Scholar
  4. Sedvall, G., Fyrö, B., Gullberg, B., Nybäck, H., Wiesel, F.-A. and Wode-Helgodt, B., 1980, Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity. Brit. J. Psychiat., 136:366.Google Scholar
  5. Sedvall, G. and Wode-Helgodt, B., 1980, Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Arch. Gen. Psychiat., 37:1113.Google Scholar
  6. Sedvall, G., Iselius, L., Nybäck, H., Oreland, L., Oxenstierna, G., Ross, S.B. and Wiesel, F.-A., 1982,. Genetic studies-of CSF monoamine metabolites. Paper presented at the Nobel conference “Frontiers in Biochemical and Pharmacological Research in Depression”, at Skokloster, Sweden, June 18–19Google Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • Göran Sedvall
    • 1
  • Gustaf Bergstrand
    • 1
  • Lars Bjerkenstedt
    • 1
  • Henrik Nybäck
    • 1
  • Gabriella Oxenstierna
    • 1
  • Frits-Axel Wiesel
    • 1
  1. 1.Department of Psychiatry and PsychologyKarolinska instituteStockholmSweden

Personalised recommendations